GlaxoSmithKline allows more developing countries to copy its medicine

A doctor gives an albendazole tablet to a child during a GlaxoSmithKline outreach event in Sri Lanka
A doctor gives medicationto a child during a GlaxoSmithKline (GSK) outreach event in Sri Lanka

One of the world’s largest pharmaceutical companies has revealed that it will enact new policies to expand access to its medicines worldwide.

GlaxoSmithKline (GSK) has taken a bold step in announcing they will not file for patents in countries which are less developed and low income. This will allow for other drug companies to copy the drug resulting in the drugs becoming much cheaper.In middle-income countries, GSK will apply for a patent but will allow it to lapse after 10 years so the companies may produce the drug after this, reported Tripe Pundit.

This policy will apply to all drugs on the World Health Organisation’s list of ‘Essential Medicines’, including some cancer drugs. In addition to this move which will result in lower prices for medicines, GSK also funds a program in poorer countries to help train health care workers. These health care workers help to teach

In addition to this move which will result in lower prices for medicines, GSK also funds a program in poorer countries to help train health care workers. These health care workers help to teach citzens about better health habits and preventative care.

Leave a Reply

Your email address will not be published. Required fields are marked *